| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $404.1M | +20.4% |
| R&D Expense | $29.6M | +18.9% |
| SG&A Expense | $58.2M | +12.9% |
| Operating Income | $142.3M | +18.0% |
| Interest Expense | $38.9M | -42.4% |
| Pre-tax Income | $105.7M | +445.0% |
| Income Tax | $13.7M | +107.3% |
| Net Income | $92.1M | -39.7% |
| EPS (Basic) | $0.75 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.6M | +3.2% |
| Short-term Investments | $24.8M | — |
| Accounts Receivable | $54.2M | +43.7% |
| Inventory | $49.5M | +45.7% |
| Current Assets | $324.1M | +29.7% |
| Total Assets | $759.5M | +17.3% |
| Current Liabilities | $84.4M | -55.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $43.9M | +929.9% |
| -48.6% |
| EPS (Diluted) | $0.71 | -44.5% |
| Long-term Debt |
| $711.3M |
| -13.3% |
| Total Liabilities | $861.4M | -11.0% |
| Stockholders' Equity | -$101.9M | +68.2% |